Screener
Acadia Pharmaceuticals ACAD Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $4.33B.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
FAQ
- What is Acadia Pharmaceuticals's market capitalization?
- Acadia Pharmaceuticals (ACAD) reported market capitalization of $4.33B in Q2 2026.
- How has Acadia Pharmaceuticals's market capitalization changed year-over-year?
- Acadia Pharmaceuticals's market capitalization increased by 15.5% year-over-year, from $3.75B to $4.33B.
- What is the long-term trend for Acadia Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's market capitalization has grown at a -12.1% compound annual growth rate (CAGR), from $8.59B to $4.52B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Acadia Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude